A Booster Vaccine for CAR-T Cells
Exclusively Licensed
Invention type: Technology
/
Case number: #19933H
The disclosure describes amphiphilic ligand conjugates comprising a chimeric antigen receptor (CAR) ligand, a lipid (diacyl lipid), a linker (hydrophilic polymers, hydrophilic amino acids, polysaccharides), compositions and methods of using the constructs are claimed, for example, to stimulate proliferation of CAR expressing cells.
Researchers
Darrell J Irvine
/
Leyuan Ma
Departments: David H Koch Institute for Integrative Cancer Res
Technology Areas: Chemicals & Materials: Polymers / Therapeutics: Cell Based Therapy, Proteins & Antibodies
Impact Areas: Healthy Living
-
compositions for chimeric antigen receptor t cell therapy and uses thereof
Hong Kong | Published application -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Australia | Pending -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Canada | Published application -
compositions for chimeric antigen receptor t cell therapy and uses thereof
China | Published application -
compositions for chimeric antigen receptor t cell therapy and uses thereof
European Patent Convention | Published application -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Japan | Granted | 7,654,240 -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Korea (south) | Published application -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Mexico | Pending -
compositions for chimeric antigen receptor t cell therapy and uses thereof
New Zealand | Pending -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Russian Federation | Granted | 2,819,805 -
compositions for chimeric antigen receptor t cell therapy and uses thereof
Japan | Published application -
compositions for chimeric antigen receptor t cell therapy and uses thereof
New Zealand | Pending -
compositions for chimeric antigen receptor t cell therapy and uses thereof
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.